Target intelligence / Profile preview

Porphine

Molecular classification
Macrocycle, Tetrapyrrole, Organic heterocyclic compound, Cofactor precursor
01

Overview

Porphine is the simplest member and parent compound of the porphyrin family, a class of heterocyclic macrocyclic organic compounds consisting of four pyrrole subunits joined by methine bridges. While porphine itself is primarily of theoretical interest due to its poor solubility, its substituted derivatives—porphyrins—are biologically indispensable, serving as the functional core for essential cofactors such as heme in hemoglobin and chlorophyll in plants. In therapeutic contexts, porphyrin-based molecules are primarily utilized as photosensitizers in photodynamic therapy (PDT); these compounds preferentially accumulate in malignant tissues and, upon activation by specific wavelengths of light, generate reactive singlet oxygen that induces localized cell death. Beyond oncology, the porphyrin biosynthetic pathway is clinically significant in the pathology of porphyrias, a group of metabolic disorders where enzyme deficiencies lead to the toxic accumulation of porphyrin intermediates. Additionally, porphyrins like heme serve as critical targets for certain antimalarial drugs, which interfere with the parasite's ability to detoxify these molecules during hemoglobin digestion.

Other names
Porphin21H,23H-Porphine21,22-DihydroporphyrinPorphyrin parent
02

Mechanism of action

Generation of reactive oxygen species (ROS) such as singlet oxygen through light-activated photosensitization; competitive binding and inhibition of heme biocrystallization in Plasmodium parasites.

03

Biological functions

Oxygen transport (as the core of heme in hemoglobin)Photosynthesis (as the core of chlorophyll)Electron transfer (as the core of cytochromes)Cofactor for enzymatic catalysis (e.g., catalase, peroxidase)Metabolic precursor to vital tetrapyrroles
04

Disease associations

Cancer (targeted via photodynamic therapy)Porphyria (disorder of biosynthesis)Age-related macular degeneration (targeted via photodynamic therapy)Malaria (involved in heme detoxification pathways)
05

Safety considerations

Systemic photosensitivity (necessitating avoidance of sunlight)Skin blistering and burns upon light exposurePotential to trigger acute porphyria attacks (with certain medications)Injection site reactions
06

Interacting drugs

Porfimer sodium (Photofrin)

5 more in the full profile.

07

Biomarkers

Urinary porphyrin levels (uroporphyrin, coproporphyrin)Plasma porphyrin levelsErythrocyte protoporphyrinFecal porphyrins

Beyond the preview

Go deeper on Porphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porphine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call